DECIBEL THERAPEUTICS INC (DBTX)

US24343R1068 - Common Stock

4.91  -0.04 (-0.81%)

After market: 4.91 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
66.00M63.96M50.23M36.09M44.08M
Research and Development
42.38M40.33M29.85M22.60M29.41M
Selling, General, and Administrative Expenses
23.61M23.63M20.38M13.49M14.68M
Operating Income
-66.00M-63.96M-50.23M-36.09M-44.08M
Interest Income/Expense
2.89M1.19M193.00K60.00K1.41M
Other Income/Expense
N/A0.0012.00K170.00KN/A
Non Recurring Items
N/AN/A0.00-3.47MN/A
Income Before Taxes
-63.11M-62.77M-50.03M-39.34M-42.67M
Income Tax
283.00K240.00K1.80MN/AN/A
Net Income
-63.39M-63.01M-54.13M7.08M-53.70M
EBITDA
-64.60M-62.49M-48.82M-34.45M-42.31M
 
Per Share Data
EPS Diluted Total Ops
-2.54-2.52-2.490.29-2.22
Non GAAP EPS
-2.53-2.51-2.64N/AN/A
 
Statistics

All data in USD

Charts